Clinical Trial Update: Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers [Phase 1]

View source ↗

Summary

Phase 1 trial assessing cabiralizumab with nivolumab in selected advanced cancers has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Malignant Glioma
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Renal Cell Carcinoma
• Solid Tumors

Drugs mentioned

• Cabiralizumab
• nivolumab (nivolumab)

Snippet

Sponsor: Five Prime Therapeutics, Inc. | Conditions: Advanced Solid Tumors, Head and Neck Cancer | Phase 1 | Status: COMPLETED | Results posted: 2022-03-09